These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 28936969)

  • 1. Systematic integration of biomedical knowledge prioritizes drugs for repurposing.
    Himmelstein DS; Lizee A; Hessler C; Brueggeman L; Chen SL; Hadley D; Green A; Khankhanian P; Baranzini SE
    Elife; 2017 Sep; 6():. PubMed ID: 28936969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative cancer pharmacogenomics to establish drug mechanism of action: drug repurposing.
    El-Hachem N; Ba-Alawi W; Smith I; Mer AS; Haibe-Kains B
    Pharmacogenomics; 2017 Nov; 18(16):1469-1472. PubMed ID: 29057710
    [No Abstract]   [Full Text] [Related]  

  • 3. Computational Methods for Drug Repurposing.
    Rapicavoli RV; Alaimo S; Ferro A; Pulvirenti A
    Adv Exp Med Biol; 2022; 1361():119-141. PubMed ID: 35230686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computationally repurposing drugs for breast cancer subtypes using a network-based approach.
    Firoozbakht F; Rezaeian I; Rueda L; Ngom A
    BMC Bioinformatics; 2022 Apr; 23(1):143. PubMed ID: 35443626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omics Data Integration and Analysis for Systems Pharmacology.
    Lim H; Xie L
    Methods Mol Biol; 2019; 1939():199-214. PubMed ID: 30848463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugst.One - a plug-and-play solution for online systems medicine and network-based drug repurposing.
    Maier A; Hartung M; Abovsky M; Adamowicz K; Bader GD; Baier S; Blumenthal DB; Chen J; Elkjaer ML; Garcia-Hernandez C; Helmy M; Hoffmann M; Jurisica I; Kotlyar M; Lazareva O; Levi H; List M; Lobentanzer S; Loscalzo J; Malod-Dognin N; Manz Q; Matschinske J; Mee M; Oubounyt M; Pastrello C; Pico AR; Pillich RT; Poschenrieder JM; Pratt D; Pržulj N; Sadegh S; Saez-Rodriguez J; Sarkar S; Shaked G; Shamir R; Trummer N; Turhan U; Wang RS; Zolotareva O; Baumbach J
    Nucleic Acids Res; 2024 Jul; 52(W1):W481-W488. PubMed ID: 38783119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing.
    Issa NT; Kruger J; Wathieu H; Raja R; Byers SW; Dakshanamurthy S
    BMC Bioinformatics; 2016 May; 17(1):202. PubMed ID: 27151405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology based drug repositioning for development of cancer therapy.
    Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
    Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational Drug Repositioning: A Lateral Approach to Traditional Drug Discovery?
    Sahu NU; Kharkar PS
    Curr Top Med Chem; 2016; 16(19):2069-77. PubMed ID: 26881717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptomic Data Mining and Repurposing for Computational Drug Discovery.
    Wang Y; Yella J; Jegga AG
    Methods Mol Biol; 2019; 1903():73-95. PubMed ID: 30547437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
    Alaimo S; Pulvirenti A
    Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational biology approaches for drug repurposing.
    Waseem T; Rajput TA; Mushtaq MS; Babar MM; Rajadas J
    Prog Mol Biol Transl Sci; 2024; 205():91-109. PubMed ID: 38789189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational drug repositioning using low-rank matrix approximation and randomized algorithms.
    Luo H; Li M; Wang S; Liu Q; Li Y; Wang J
    Bioinformatics; 2018 Jun; 34(11):1904-1912. PubMed ID: 29365057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge graphs and their applications in drug discovery.
    MacLean F
    Expert Opin Drug Discov; 2021 Sep; 16(9):1057-1069. PubMed ID: 33843398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eRepo-ORP: Exploring the Opportunity Space to Combat Orphan Diseases with Existing Drugs.
    Brylinski M; Naderi M; Govindaraj RG; Lemoine J
    J Mol Biol; 2018 Jul; 430(15):2266-2273. PubMed ID: 29237557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Computational Functional Genomics in Drug Discovery and Repurposing for Analgesic Indications.
    Lötsch J; Kringel D
    Clin Pharmacol Ther; 2018 Jun; 103(6):975-978. PubMed ID: 29350398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overcoming Sparseness of Biomedical Networks to Identify Drug Repositioning Candidates.
    Poleksic A
    IEEE/ACM Trans Comput Biol Bioinform; 2022; 19(4):2377-2384. PubMed ID: 33591920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Drug Expression Profiles and Machine Learning Approach for Drug Repurposing.
    Zhao K; So HC
    Methods Mol Biol; 2019; 1903():219-237. PubMed ID: 30547445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prioritization of candidate cancer drugs based on a drug functional similarity network constructed by integrating pathway activities and drug activities.
    Di J; Zheng B; Kong Q; Jiang Y; Liu S; Yang Y; Han X; Sheng Y; Zhang Y; Cheng L; Han J
    Mol Oncol; 2019 Oct; 13(10):2259-2277. PubMed ID: 31408580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.